MAPT and Alzheimer disease: Of the studies that analyzed known biomarkers of AD-related pathology (e.g., ApoE, tau, Aβ), three either stratified or adjusted their analyses for the presence of the APOE ε4 SNP (43, 58, 62), while three did not control for genotype (57, 63, 64).